Cargando…
Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
BACKGROUND AND PURPOSE: Doxorubicin anti‐cancer therapy is associated with cardiotoxicity, resulting from DNA damage response (DDR). Hepatocyte growth factor (HGF) protects cardiomyocytes from injury, but its effective use is compromised by low biodistribution. In this study, we have investigated wh...
Autores principales: | Gallo, Simona, Spilinga, Martina, Albano, Raffaella, Ferrauto, Giuseppe, Di Gregorio, Enza, Casanova, Elena, Balmativola, Davide, Bonzano, Alessandro, Boccaccio, Carla, Sapino, Anna, Comoglio, Paolo Maria, Crepaldi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280013/ https://www.ncbi.nlm.nih.gov/pubmed/32133617 http://dx.doi.org/10.1111/bph.15039 |
Ejemplares similares
-
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
por: Gallo, Simona, et al.
Publicado: (2020) -
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
por: Modica, Chiara, et al.
Publicado: (2020) -
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
por: Gallo, Simona, et al.
Publicado: (2022) -
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
por: Gallo, Simona, et al.
Publicado: (2019) -
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy
por: Gallo, S, et al.
Publicado: (2014)